ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy in Patients With ST-segment Elevation Myocardial Infarction

Trial Profile

ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy in Patients With ST-segment Elevation Myocardial Infarction

Completed
Phase of Trial: Phase II/III

Latest Information Update: 01 Feb 2016

At a glance

  • Drugs Prasugrel (Primary) ; Clopidogrel
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Pharmacodynamics; Pharmacogenomic
  • Acronyms RAPID STEMI
  • Most Recent Events

    • 11 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
    • 07 Jul 2012 Planned end date changed from 1 Mar 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
    • 18 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top